Skip to main content
. 2012 Jul 15;263(2):167–175. doi: 10.1007/s00406-012-0342-7

Table 2.

Univariate and multivariate regression analyses to detect independent patient and treatment characteristics to predict initial seizure threshold (IST), and mixed analyses to detect independent predictors of the variation in seizure threshold (ST) during the course of electroconvulsive therapy (ECT)

Univariate correlates of IST at baseline Multivariate correlates of ISTa at baseline Multivariate correlates of STa during follow-up
β-coefficient P value β-coefficient P value β-coefficient P value
Patient characteristics
Male gender −0.043 0.682
Age, in years 0.466 <0.001 0.238 0.033 0.279 0.009
Body mass index, in kg/m2 −0.156 0.143
CIRS scored 0.385 <0.001 0.154 0.131 0.127 0.227
Diagnostic category, according to axis 1 of DSM-IV-Rf
 Depressive disorder without psychotic features −0.064 0.544
 Depressive disorder with psychotic features 0.030 0.781
 Bipolar disorder, depressive episode 0.076 0.476
 Other disorderse −0.046 0.664
Documented or clinically suspected personality disorder present, according to axis 2 of DSM-IV-R −0.134 0.207
MADRSb score at baseline 0.082 0.450
MMSEc score at baseline −0.331 0.002 −0.045 0.641 0.058 0.549
Treatment characteristics            
Had previous course(s) of ECT 0.346 0.001 0.059 0.579 −0.052 0.564
Days between last ECT and index ECT −0.064 0.746
Use of seizure threshold influencing concomitant pharmacotherapy
 Benzodiazepines 0.033 0.758
 Antiepileptics 0.027 0.803
 Antidepressants 0.084 0.431
 Antipsychotics −0.112 0.289
Electrode placement is bifrontotemporal 0.546 <0.001 0.424 <0.001 0.348 <0.001
Dynamic impedance −0.248 0.018 −0.082 0.344 −0.107 0.062
Etomidate dose −0.084 0.427
Succinylcholine dose −0.295 0.005 −0.071 0.452 −0.056 0.376

aMultivariate regression analysis and mixed analysis only for variables showing P < 0.10 at univariate analysis

bMontgomery–Åsberg Depression Rating Scale

cMini-Mental State Examination

dCumulative Illness Rating Scale

eSchizophrenia (n = 2) and malignant neuroleptic syndrome (n = 1)

fDiagnostic and Statistical Manual of Mental Disorders